Why is India on the U.S. blacklist on fentanyl?, Pg 13.

Key Highlights:

• 23 countries listed as major drug sources/transit hubs; Afghanistan, Bolivia, Myanmar, Colombia, Venezuela flagged for “failure” under global drug-control norms.
• India and China identified for diversion of precursor chemicals to illegal supply chains.
• Fentanyl: synthetic opioid, ~50 times more potent than heroin; leading cause of overdose deaths in the U.S.
• From Aug 2023–Aug 2024, over 57,000 U.S. deaths from opioid overdose, mostly fentanyl-linked.
• In 2022, DEA seized 50.6 million fentanyl-laced pills, enough for 379 million fatal doses.
• Two Indian firms (Raxuter Chemicals, Athos Chemicals) charged in 2025 for conspiring to export fentanyl precursors; U.S. revoked visas of executives involved.

Detailed Insights:

• Major’s List purpose: Identifies regions facilitating narcotics flow; not necessarily a reflection of state enforcement capability but of trafficking significance.
• Fentanyl production: Unlike plant-derived drugs (heroin, cocaine), fentanyl is lab-synthesised using precursors like NPP and 4-ANPP with legitimate uses, making regulation difficult.
• Supply chain: China & India → precursors; Mexican cartels → fentanyl synthesis & distribution into U.S. markets.
• U.S. response: Criminal prosecutions, trade penalties, and diplomatic pressure on source countries; intensified border surveillance.
• India’s challenge: Must prevent diversion of legitimate chemical/pharmaceutical industries into illicit networks to avoid global scrutiny and sanctions.

Concepts Involved:

• Fentanyl: Synthetic opioid binding to mu-opioid receptors, causing respiratory depression; highly potent (2 mg fatal dose).
• Naloxone: Opioid antagonist used to reverse overdoses by displacing fentanyl from receptors.
• Precursors (NPP, 4-ANPP): Industrial chemicals with dual-use potential, easily converted into fentanyl with basic lab setups.